[HTML][HTML] A Systematic Review of the Role of Purinergic Signalling Pathway in the Treatment of COVID-19

VG Korb, IC Schultz, LR Beckenkamp… - International Journal of …, 2023 - mdpi.com
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has become a global health concern. Three years …

[HTML][HTML] Integrated microbiome and metabolome analysis reveals the potential therapeutic mechanism of Qing-Fei-Pai-Du decoction in mice with coronavirus-induced …

G Wu, W Zhang, N Zheng, X Zu, S Tian… - Frontiers in Cellular …, 2022 - frontiersin.org
Current studies have shown that gut microbiota may be closely related to the severity of
coronavirus disease 2019 (COVID-19) by regulating the host immune response. Qing-Fei …

Alterations in CD39/CD73 axis of T cells associated with COVID‐19 severity

GP Dorneles, PC Teixeira, IM da Silva… - Journal of Cellular …, 2022 - Wiley Online Library
Purinergic signaling modulates immune function and is involved in the
immunopathogenesis of several viral infections. This study aimed to investigate alterations …

[HTML][HTML] The potential of purinergic signaling to thwart viruses including SARS-CoV-2

D Ferrari, M Rubini, JS Burns - Frontiers in Immunology, 2022 - frontiersin.org
A long-shared evolutionary history is congruent with the multiple roles played by purinergic
signaling in viral infection, replication and host responses that can assist or hinder viral …

Human blood metabolites and risk of severe COVID‐19: A Mendelian randomization study

W Shang, H Qian, X Shen, Z Wen… - European Journal of …, 2023 - Wiley Online Library
Background Evidence supports the observational associations of human blood metabolites
with the risk of severe COVID‐19. However, little is known about the potential pathological …

[HTML][HTML] Investigating the shared genetic architecture between COVID-19 and obesity: a large-scale genome wide cross-trait analysis

Y Chen, C Fan, J Liu - Frontiers in Endocrinology, 2024 - frontiersin.org
Observational studies have reported high comorbidity between obesity and severe COVID-
19. The aim of this study is to explore whether genetic factors are involved in the co …

[HTML][HTML] Phase 2 randomised placebo-controlled trial of spironolactone and dexamethasone versus dexamethasone in COVID-19 hospitalised patients in Delhi

B Wadhwa, V Malhotra, S Kerai, F Husain… - BMC Infectious …, 2023 - Springer
Background In this phase 2 randomised placebo-controlled clinical trial in patients with
COVID-19, we hypothesised that blocking mineralocorticoid receptors using a combination …

[HTML][HTML] Proteomic snapshot of saliva samples predicts new pathways implicated in SARS-CoV-2 pathogenesis

E Moreno, S Ciordia, SM Fátima, D Jiménez… - Clinical Proteomics, 2024 - Springer
Background Information on the microbiome's human pathways and active members that can
affect SARS-CoV-2 susceptibility and pathogenesis in the salivary proteome is very scarce …

Purinergic signaling pathway in severe COVID-19

L Arruvito, I Sananez, V Seery, C Russo… - Current Opinion in …, 2023 - Elsevier
Substantial efforts have been made to understand the immune response during severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, in order to identify and …

Decreased circulating CD73 and adenosine deaminase are associated with disease severity in hospitalized patients with COVID-19

J Rud, RR Riker, A Eldridge, C Lord… - International journal …, 2023 - journals.sagepub.com
Objective SARS-CoV-2 infection has been shown to result in increased circulating levels of
adenosine triphosphate and adenosine diphosphate and decreased levels of adenosine …